These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 6417770

  • 1. Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin.
    Heilesen AM, Permin H, Koch C, Høiby N.
    Scand J Infect Dis; 1983; 15(3):271-6. PubMed ID: 6417770
    [Abstract] [Full Text] [Related]

  • 2. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G, Agostini M, Barlocco G, Bonomi U, Borgo G, Bozzino L, Cabrini G, Cappelletti LM, Castellani L, Conforti M.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [Abstract] [Full Text] [Related]

  • 3. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE, Høiby N.
    Scand J Infect Dis Suppl; 1981 Jul; 29():87-91. PubMed ID: 6458884
    [Abstract] [Full Text] [Related]

  • 4. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
    Permin H, Koch C, Høiby N, Christensen HO, Møller AF, Møller S.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
    [Abstract] [Full Text] [Related]

  • 5. Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
    Fitzpatrick SB, Rosenstein BJ.
    Clin Pediatr (Phila); 1983 Sep; 22(9):628-30. PubMed ID: 6224623
    [Abstract] [Full Text] [Related]

  • 6. Synergy of new C-3 substituted cephalosporins and tobramycin against Pseudomonas aeruginosa and Pseudomonas cepacia.
    Chin NX, Neu HC.
    Diagn Microbiol Infect Dis; 1989 Sep; 12(4):343-9. PubMed ID: 2512049
    [Abstract] [Full Text] [Related]

  • 7. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
    Strandvik B, Malmborg AS, Alfredson H, Ericsson A.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():283-7. PubMed ID: 6352633
    [Abstract] [Full Text] [Related]

  • 8. In vitro comparison of cefpirome and four other beta-lactam antibiotics alone and in combination with tobramycin against clinical isolates of Pseudomonas aeruginosa.
    Cabezudo I, Pfaller M, Bale M, Wenzel R.
    Diagn Microbiol Infect Dis; 1989 Jul; 12(4):337-41. PubMed ID: 2512048
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.
    Master V, Roberts GW, Coulthard KP, Baghurst PA, Martin A, Roberts ME, Onishko CR, Martin AJ, Linke RJ, Holmes M, Jarvinen A, Kennedy D, Colebatch KA, Hansman D, Parsons DW.
    Pediatr Pulmonol; 2001 May; 31(5):367-76. PubMed ID: 11340683
    [Abstract] [Full Text] [Related]

  • 10. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O, Giwercman B, Pedersen SS, Høiby N.
    APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
    [Abstract] [Full Text] [Related]

  • 11. Ceftazidime - a significant advance in the treatment of cystic fibrosis.
    David TJ, Phillips BM, Connor PJ.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():337-40. PubMed ID: 6352639
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE, Eriksen KR, Feddersen C, Flensborg EW, Høiby N, Norn S, Rosendal K, Schiøtz PO, Skov PS.
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility of Pseudomonas aeruginosa before and after initiation of inhaled tobramycin in Bulgaria.
    Petrova G, Strateva T, Miteva D, Lazova S, Perenovska P.
    J Infect Dev Ctries; 2016 Nov 24; 10(11):1265-1267. PubMed ID: 27886041
    [Abstract] [Full Text] [Related]

  • 14. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
    Wu YL, Scott EM, Po AL, Tariq VN.
    APMIS; 1999 Jun 24; 107(6):585-92. PubMed ID: 10379686
    [Abstract] [Full Text] [Related]

  • 15. Continuous infusion of ceftazidime with a portable pump is as effective as thrice-a-day bolus in cystic fibrosis children.
    Rappaz I, Decosterd LA, Bille J, Pilet M, Bélaz N, Roulet M.
    Eur J Pediatr; 2000 Dec 24; 159(12):919-25. PubMed ID: 11131352
    [Abstract] [Full Text] [Related]

  • 16. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS, Neu HC.
    Antimicrob Agents Chemother; 1981 Oct 24; 20(4):545-6. PubMed ID: 6282199
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T, Petrova G, Mitov I.
    J Chemother; 2010 Dec 24; 22(6):378-83. PubMed ID: 21303744
    [Abstract] [Full Text] [Related]

  • 18. The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis.
    Kelly N, Falkiner FR, Keane CT, Murphy M, Fitzgerald MX.
    J Antimicrob Chemother; 1981 Sep 24; 8 Suppl B():175-8. PubMed ID: 19802982
    [Abstract] [Full Text] [Related]

  • 19. Comparison between the in-vitro activity of new agents on Pseudomonas aeruginosa isolates from cystic fibrosis patients and other chronic infections.
    Gordts B, Vandenborre C, VanderAuwera P, Butzler JP.
    J Antimicrob Chemother; 1984 Jul 24; 14(1):25-9. PubMed ID: 6434504
    [Abstract] [Full Text] [Related]

  • 20. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC, Richard G, Burghoffer B, Daguet GL.
    Pathol Biol (Paris); 1982 Jun 24; 30(6):426-31. PubMed ID: 6810286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.